Zentera completes $75M series B financing as it aims for Hong Kong listing in 2022 Aug. 2, 2021 By David Ho Zentera Therapeutics Inc. completed a $75 million series B financing round to help further its candidates in China, as it paves the way for a listing in Hong Kong next year.Read More
Addition of GEN-1 to standard NAC shows safety and efficacy in phase I ovarian cancer study Aug. 2, 2021
Targeting hypoxia-induced metastatic genes shows therapeutic potential in uveal melanoma Aug. 2, 2021
RSS